Table 1.
Background demographics (safety analysis set).
| mRNA-1273 |
Placebo |
|||||
|---|---|---|---|---|---|---|
| Total (N = 150) |
≥20 to <65 years (N = 100) |
≥65 years (N = 50) |
Total (N = 50) |
≥20 to <65 years (N = 40) |
≥65 years (N = 10) |
|
| Age years, mean (range) | 53.3 (20–77) | 45.1 (20–64) | 69.6 (65–77) | 52.4 (20–76) | 48.2 (20–64) | 69.5 (67–76) |
| Sex, n (%) | ||||||
| Male | 85 (56.7) | 54 (54.0) | 31 (62.0) | 27 (54.0) | 21 (52.5) | 6 (60.0) |
| Female | 65 (43.3) | 46 (46.0) | 19 (38.0) | 23 (46.0) | 19 (47.5) | 4 (40.0) |
| Race, n (%) | ||||||
| Japanese | 150 (100) | 100 (100) | 50 (100) | 50 (100) | 40 (100) | 10 (100) |
| Other | 0 | 0 | 0 | 0 | 0 | 0 |
| BMI kg/m2, mean (SD) | 22.39 (2.65) | 22.12 (2.66) | 22.94 (2.57) | 23.35 (2.60) | 23.36 (2.72) | 23.30 (2.17) |
BMI = body mass index, SD = standard deviation.
Percentages are based on the number of randomised participants.